Insulin just a cash cow
What happens when the demand for a product goes down, or the manufacturer thinks that it will go down in the near future? The price drops (“Drugmaker Eli Lilly announces half-priced generic of its insulin product Humalog,” Web, March 4). The good news/bad news story about insulin is that it was and is a lifesaver for Type 1 diabetics, but a lifelong, chronic, disease-causing option for Type 2 diabetics.
Oprah is losing money on Weight Watchers, her darling investment. Articles on “keto crotch” and bad breath are appearing in women’s magazines across from ads for Weight Watchers. If you read the fine print, you can see that the American Diabetes Association is now including the low-carb diet as a treatment option. They still cannot call it the ketogenic diet because it would make them look like the criminals that they are. The ketogenic diet reverses all makers for diabetes, and unsurprisingly followers of it stop their insulin in a matter of a few weeks. This result is independent of how long they were on the drug.
There is nothing new about the ketogenic diet and what it offers diabetics. A leading authority and pioneer in the treatment of Type 2 diabetes in the early part of the 20th century recommended the ketogenic diet as a treatment option. Unfortunately, with the advent of insulin, the diet was thought to be unnecessary. With it, you could live with blood insulin levels five times the normal level and gradually get worse over the years, subjecting yourself to the majority of associated chronic diseases. This was thought to be perfectly fine by the medical profession (and of course the pharmaceutical industry).
In the past 20 years, the Internet has turned on the light in the kitchen, and the roaches are scrambling for cover. If 30 million U.S. citizens are diabetic, you get 1.5 million new cases per year and the pathetic Centers for Disease Control and Prevention is worried about measles instead, isn’t it way past time to stop paying the roaches and get healthy?